AbCellera Biologics Inc. (ABCL): Price and Financial Metrics
ABCL Price/Volume Stats
| Current price | $2.44 | 52-week high | $3.76 |
| Prev. close | $2.37 | 52-week low | $1.89 |
| Day low | $2.38 | Volume | 3,800,062 |
| Day high | $2.49 | Avg. volume | 4,119,446 |
| 50-day MA | $2.23 | Dividend yield | N/A |
| 200-day MA | $2.65 | Market Cap | 728.15M |
ABCL Stock Price Chart Interactive Chart >
AbCellera Biologics Inc. (ABCL) Company Bio
AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics. It was founded in 2012 and headquartered in Vancouver, British Columbia.
ABCL Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ABCL Price Returns
| 1-mo | 21.39% |
| 3-mo | 4.72% |
| 6-mo | -18.67% |
| 1-year | -35.45% |
| 3-year | -68.84% |
| 5-year | N/A |
| YTD | -16.72% |
| 2024 | -48.69% |
| 2023 | -43.63% |
| 2022 | -29.16% |
| 2021 | -64.46% |
| 2020 | N/A |